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E-mail address: katharina.paschinger@boku.ac.at (In previous work we showed that Ag5, a major diagnostic antigen from the metacestode of Echinococcus
granulosus, possesses a dominant sugar epitope that upon removal results in abolition of most of the anti-
gen immunoreactivity with patient sera. Analysis of this glycan modiﬁcation has now been performed by
western blotting and mass spectrometry. Reactivity to both a speciﬁc monoclonal antibody (TEPC15) and
human C-reactive protein as well as the presence of a modiﬁcation of 165 mass units, as detected by mass
spectrometry of both glycopeptides and released N-glycans, indicated that the immunodominant sugar
epitope of the Ag5 38 kDa subunit is a biantennary structure modiﬁed by phosphorylcholine. We believe
this is the ﬁrst time that such a modiﬁcation has been proven in cestodes and provides the structural
basis for understanding the antigenicity of this major E. granulosus component.
 2012 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Cystic hydatid disease is a widespread zoonosis (i.e., a disease
transmitted from the biological animal host to humans) that has
the dog as a deﬁnitive host and different ungulates (typically
sheep) as intermediate ones. Humans accidentally contract the
disease by ingestion of parasite eggs released by the dog, which
can develop as a larval cyst in liver, lung or, less frequently, other
tissues (McManus et al., 2003). The infective agent, the (tape-
worm) Echinococcus granulosus, belongs to the Cestoda class, a
group of obligate parasitic platyhelminths (ﬂatworms) closely
related to trematodes, of which the best studied genus is the par-
asitic Schistosoma (Gryseels et al., 2006). A number of antigens,
including many glycoproteins, are produced by the metacestode
of E. granulosus and have been extensively used for the detection
of antibodies in patients’ sera. Among them, antigens AgB and
Ag5 have been the most studied components of the parasite,
due to their high concentration in hydatid cyst ﬂuid and their
immunoreactivity (Pozzuoli et al., 1975; Gonzalez-Sapienza
et al., 2000; Lorenzo et al., 2005a; Carmena et al., 2007). While
AgB is a 160 kDa thermostable lipoprotein, Ag5 is a dimeric pro-
tein composed of 22 and 38 kDa subunits linked by a disulphide
bridge, with both subunits bearing an N-glycan modiﬁcation
(Lorenzo et al., 2003).Inc. Published by Elsevier Ltd. Op
x: +43 1 47654 6076.
K. Paschinger).In previous work we analysed the immunogenicity of Ag5 and
found that most patient antibodies were unreactive towards
either the recombinant antigen produced in Escherichia coli or
the deglycosylated native antigen. We also demonstrated that
the immunorelevant epitope is a sugar moiety attached to the
38 kDa subunit of Ag5 (Lorenzo et al., 2003). This is in agreement
with the immunodominant response against glycosidic epitopes
of E. granulosus that has been reported in a model of secondary
infection (Ferragut and Nieto, 1996) as well as with the diagnos-
tic relevance of the Galb1,6Gal-modiﬁed glycolipids and Gala1,
4Gal-modiﬁed O-linked parasite glycans (Persat et al., 1992;
Hülsmeier et al., 2002, 2010; Diaz et al., 2009; Yamano et al.,
2009). These determinants are recognised by the sera of patients
infected with other cestode species, including the causative agent
of alveolar echinococcosis, Echinococcus multilocularis. We found a
similar pattern of cross-reactivity associated with the immuno-
dominant glycan epitope of E. granulosus antigen Ag5 (Lorenzo
et al., 2005b).
To provide structural information on this major epitope of Ag5,
in this study the N-glycans of the large subunit of Ag5 were exam-
ined. The mass spectrometric analysis of the glycopeptides and the
released N-glycans showed that the 38 kDa subunit carries a bi
antennary N-glycan modiﬁed with phosphorylcholine. Although
this result could be predicted on the basis of antibody reactivity
(Shepherd and McManus, 1987; Lightowlers et al., 1989; Lorenzo
et al., 2005a), we believe this is the ﬁrst structural proof for the
modiﬁcation of an N-glycan with this moiety in a species other
than a nematode.en access under CC BY-NC-ND license. 
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2.1. Materials
Ag5 was afﬁnity puriﬁed from bovine hydatid cyst ﬂuid using
the agarose immobilized monoclonal antibody 1D1 as described
previously (Lorenzo et al., 2003).
For screening the presence of either core fucose or phosphoryl-
choline modiﬁcations, 2 lg of untreated or PNGase F-treated Ag5
were applied to a standard SDS–PAGE gel. For PNGase F treatment,
Ag5 (8 lg) was ﬁrst denatured in 10 ll of 0.5% SDS for 5 min at
95 C, prior to addition of 3 ll of McIlvaine phosphate-citrate buf-
fer, pH 7.5, and 2 ll of PNGase F (peptide:N-glycosidase F; Roche,
Germany), and incubated for 2 days at 37 C. After SDS–PAGE at
200 V for 50 min, proteins were subjected to western blotting
(semi-dry blotting, 20 V, 50 min) and the nitrocellulose membrane
was blocked with Tris-buffered saline supplemented with 0.05%
Tween-20 and 0.5% BSA (TTBS/BSA) for 1 h. The membrane was
then incubated for 1 h with either biotinylated Aleuria aurantia lec-
tin (AAL; Vector Laboratories, USA; 1:1,000) or TEPC15 (anti-phos-
phorylcholine; Sigma–Aldrich, USA; 1:250), washed thrice with
TTBS and incubated with alkaline phosphatase conjugates of either
anti-biotin or anti-IgA (1:10,000; Sigma–Aldrich) prior to washing
again and development using SigmaFAST™ 5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium. In the case of detection
with C-reactive protein (CRP; Sigma–Aldrich), the membrane was
incubated with 50 lg/ml of human CRP, followed by 1:750 rabbit
anti-CRP (DAKO, Denmark) and ﬁnally 1:2,000 alkaline phospha-
tase conjugated goat anti-rabbit (Vector Laboratories, USA) prior
to colour development.2.2. Tryptic peptide mapping
Ten micrograms of untreated Ag5 were applied to a SDS–PAGE
gel, stained with Coomassie Brilliant Blue G-250 and the bands ex-
cised. The gel band pieces were washed serially with acetonitrile,
twice with 50% acetonitrile in water, 1:1 0.1 M ammonium bicar-
bonate/acetonitrile and again with acetonitrile prior to drying, fol-
lowed by reduction with 10 mM of DTT at 56 C for 1 h, alkylation
with 55 mM of iodoacetamide in the dark for 45 min and once
again serially washing, with 50% acetonitrile in water (twice), 1:1
ammonium bicarbonate:acetonitrile and with 100% acetonitrile.
The gel pieces were again dried and 15 ll of a 1:2 mixture of
50 ng/ll trypsin/0.1 M ammonium bicarbonate were applied; the
gel pieces were then covered with 0.1 M ammonium bicarbonate
and incubated overnight at 37 C. The peptides were extracted
with 660:330:1 acetonitrile/water/triﬂuoroacetic acid, dried and
dissolved in the same. An aliquot (0.25 ll) was directly spotted
onto a ground steel sample plate and analysed by MALDI-TOF MS
with either a-cyanocinnamic acid (ACH), sinapinic acid (SA) or 6-
aza-2-thiothymine (ATT) as matrices. The samples were analysed
in positive ion mode using a Bruker Ultraﬂex I (Bruker Daltonics,
Germany) equipped with a nitrogen laser (337 nm; laser frequency
of 50 Hz and pulse length of 200 ns); typically 400–1000 shots
were summed. Data were analysed and predicted using the Pro-
teinProspector MS-Fit and MS-Digest on-line software (http://
prospector.ucsf.edu).2.3. Glycan release and analysis
Approximately one-half of the tryptic peptides were dried, dis-
solved in 15 ll of water and heat-treated for 5 min at 95 C; 15 ll
of 0.2 M ammonium acetate, pH 5, and 0.5 ll of PNGase A (Roche,
Germany) were added and the sample incubated overnight at
37 C; a portion was retained for direct analysis by MALDI-TOFMS. The rest of the sample was then acidiﬁed with 6 ll of 10% ace-
tic acid and applied to a mini-column of 50 ll Dowex 50 W pre-
washed with 3 ml of 2% acetic acid; the column was then washed
thrice with 300 ll of 2% acetic acid, the sample lyophilised and
dissolved in 10 ll of water prior to application to another mini-col-
umn consisting of 1–2 mm of C18 LiChroprep (Merck) and 2–3 mm
of porous graphitised carbon (with material taken from a Supel-
clean ENVI-Carb column; Supelco, USA), pre-washed with 2 ml of
acetonitrile and 4 ml of water. After sample application, the col-
umn was washed six times with 250 ll of water and four times
with 250 ll of 40% acetonitrile. The 40% acetonitrile fractions
containing glycans were pooled, dried in a SpeedVac and analysed
by MALDI-TOF MS (Bruker Ultraﬂex I as above) using ATT as a
matrix.
In a separate experiment, 2 lg of puriﬁed Ag5 were incubated
overnight with PNGase F in solution as described above
(Section 2.1); the incubation was precipitated with a ﬁve volume
excess of methanol and the supernatant was vacuum-dried prior
to puriﬁcation of the glycan on C18 Lichroprep and porous graph-
itised carbon (also as above). The glycan was then subject to pyr-
idylamination as described (Paschinger et al., 2012), but on a
tenth of the normal scale (i.e., with a tenth of the normal amounts
of derivatisation reagents), prior to gel ﬁltration and MALDI-TOF
MS. For removal of phosphorylcholine, a portion of the glycan sam-
ple was dried and incubated overnight at 0 C with 3 ll of 48% (v/v)
hydroﬂuoric acid prior to evaporation; the sample was diluted in
water and re-evaporated, prior to dissolving once again and analy-
sis by MALDI-TOF MS.3. Results and discussion
3.1. PNGase F sensitivity of Ag5 epitopes
Phosphorylcholine is a known component of a number of glyco-
conjugates including lipopolysaccharides from some bacteria, gly-
colipids from nematodes and earthworms and N-linked glycans
from nematodes (Sugita et al., 1992; Lochnit et al., 1998; Pöltl
et al., 2007; Fox et al., 2008). To conﬁrm previous data suggesting
the presence of phosphorylcholine on Ag5, blotting with the mono-
clonal IgA TEPC15 (Leon and Young, 1971) and with human CRP, a
pentraxin produced as part of the inﬂammatory response and also
known to bind phosphorylcholine, was performed on untreated
and PNGase F-treated E. granulosus Ag5. The blots indicate that
the reactivity of the 38 kDa subunit to the TEPC15 antibody and
to CRP is PNGase F-sensitive (Fig. 1A and B). Similarly, the reactiv-
ity of Ag5 to the fucose-speciﬁc AAL (Iskratsch et al., 2009) is also
PNGase F sensitive (Fig. 1C); this enzyme can release N-glycans
modiﬁed with core a1,6-fucose, but not those with core a1,3-fu-
cose (Tretter et al., 1991). Indeed, no reactivity to the core a1,3-fu-
cose speciﬁc anti-horseradish peroxidase antiserum was observed
(data not shown). The reduction in molecular mass accompanying
PNGase F treatment of Ag5 was conﬁrmed as judged by the shift
observed on the Coomassie-stained gel (Fig. 1D). The sensitivity
of TEPC15, CRP and AAL staining to treatment by this glycosidase
was indicative that phosphorylcholine and core a1,6-fucose moie-
ties are associated with N-glycans on the Ag5 38 kDa subunit.3.2. Mass spectrometry of Ag5 (glyco)peptides
The tryptic peptides derived from the 38 kDa subunit of Ag5
were examined by MALDI-TOF MS using three different matrices:
ACH, SA and ATT. Relative intensities varied, but a large number
of peptides were observed using all three matrices (Table 1;
Fig. 2). The peptide mapping data obtained was compatible with
the Ag5 genome sequence from E. granulosus produced by the
Fig. 1. Antibody and lectin reactivity of Echinococcus granulosus antigen Ag5. A
sample of puriﬁed Ag5 (untreated or treated with PNGase F; F or +F) was subject
to western blotting with either (A) the anti-phosphorylcholine monoclonal
antibody TEPC15, (B) human C-reactive protein or (C) Aleuria aurantia lectin.
Coomassie Blue staining (D) demonstrates the shift resulting from PNGase F
treatment; the faint lower band of around 30 kDa corresponds to PNGase F. Equal
amounts of the native and deglycosylated forms of Ag5 were applied for both
blotting and Coomassie staining.
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ger.ac.uk/cgi-bin/submitblast/Echinococcus) as well as with the
orthologous sequence from E. multilocularis. We therefore conclude
that the correct sequence for residues 110–124 is DLVVIHPDW-
VAQRVDS and not the previously-published AWSSFIRIGLPNVLI
(Lorenzo et al., 2003); furthermore, residue 221 is indeed Cys
and not Arg. Additionally, during reviewing of this manuscript, a
new Ag5 cDNA sequence from a Chinese isolate was published
(Li et al., in press) which is also in accordance with our new mass
spectrometric data. The overall sequence coverage is some 71%;
however, one predicted tryptic peptide accounting for over 10%
of the sequence (mass over 4 kDa) was not observed. Four molec-
ular species of m/z 805, 841, 1847 and 1970 present in the spectra
are not explained by the predicted N-glycosylated amino acid se-
quence of Ag5.
Striking, however, was the presence of three peptides (m/z
2711.1, 2876.2 and 3041.3) in the spectrum acquired when using
ATT as matrix, none of which corresponded to a predicted peptide.
The later data on the released N-glycans (see Section 3.3 below)Table 1
Tryptic peptide mapping of the Echinococcus granulosus antigen Ag5 38 kDa subunit. The
peptides were observed (a-cyanocinnamic acid, ACH; 6-aza-2-thiothymine, ATT; sinapinic
detected peptide, the mass is compatible with an apparent incomplete carboxyamidomethy
Observed m/z value Predicted m/z value Matrix
884.617 884.472 ATT
940.627 940.568 ACH
1018.555 1018.5164 ACH, ATT, SA
1231.736 1231.668 ACH, ATT, SA
1267.825 1266.607 ACH, ATT
1272.708 1272.652 ACH, SA
1426.682 1426.620 ACH, ATT, SA
1466.873 1466.819 ACH, ATT
1771.952 1771.973 ACH, ATT
1815.881 1815.912 ATT, SA
1834.913 1834.960 ACH, ATT
1898.907 1898.907 SA
1956.220 1955.974 ATT
1971.971 1971.958 SA
2123.818 2123.818 ATT, SA
2138.373 2138.979 ACH
2585.214 2585.274 ACH, ATT, SA
2711.167 2711.141 ATT
2842.183 2842.423 ACH, ATT, SA
2876.242 2876.196 ATT
3041.324 3041.251 ATTenabled us to predict that these masses corresponded to glycopep-
tides. The difference in m/z of these three peptides (165 mass
units) would be in agreement with the presence of phosphorylcho-
line on two of these glycopeptides and MS/MS of the glycopeptide
of m/z 3041 showed the presence of a fragment of m/z 368, which
corresponds to a phosphorylcholine-modiﬁed HexNAc residue. In
contrast, the MS/MS spectrum of the m/z 2711 glycopeptide
showed the presence of a fragment corresponding to unsubstituted
terminal HexNAc (m/z 203.7). These data also indicate the utility of
ATT not just as a matrix for glycans but also for glycopeptides (Lat-
tová et al., 2007).
The peptides present after incubation with PNGase A were also
analysed; whereas the aforementioned three putative glycopep-
tides were no longer detected, a new molecular ion of m/z
1267.8 was observed in the treated sample (Fig. 2, inset). This pep-
tide is predicted to correspond to the deglycosylated peptide, AA-
NYDASEGLTR, in which, as expected (Plummer et al., 1984), the
glycosylated asparagine has been converted to aspartate. Thereby,
a mass difference of +1 is observed as compared to the predicted
mass of the non-glycosylated asparagine-containing peptide. This
result is compatible with glycosylation of Asn25 of the 38 kDa sub-
unit (i.e., Asn213 of the unprocessed Ag5 precursor); this is the only
asparagine in the context of an Asn-Xaa-Ser/Thr sequon in the se-
quence of this subunit.3.3. Analysis of the released Ag5 N-glycan
The nature of the N-glycan modiﬁcation was studied in two
independent experiments; in the ﬁrst, tryptic peptides were trea-
ted with PNGase A and puriﬁed using two mini-columns, whereas
in the second, denatured intact Ag5 was treated with PNGase F in
solution. The results were similar in that a single major species (m/
z 1793.6) was observed (Fig. 3A; only data for the PNGase A-re-
leased free glycan is shown). MS/MS (Fig. 3D) indicated the pres-
ence of fragments of m/z 368.9 and 530.9 compatible with these
being Hex0–1HexNAc1PC1; therefore, an overall composition of
Hex3HexNAc4dHex1PC2 could be proposed for an [M+H]+ ion,
whereby the deoxyhexose (dHex) residue is presumed, due to
the AAL staining, to be fucose. Upon treatment with hydroﬂuoric
acid known to remove phosphorylcholine and core a1,3-fucose
residues (Haslam et al., 1997; Pöltl et al., 2007), the m/z 1793.6observed and calculated m/z values are listed, as well as the matrix with which the
acid SA) and the residues to which these species are predicted to correspond. For one
lation (‘CAM lacking’). The peptides withm/z 2163 and 2273 are derived from trypsin.
Corresponding residues Comments
213–220
173–180
89–98
123–133
21–32 Deglycosylated, Asp
11–20
240–253
201–212
33–48 1 missed cleavage
183–196
279–293
134–152 CAM lacking
134–152
182–196 1 missed cleavage
153–172
260–277 1 missed cleavage
101–122
21–32 +Hex3HexNAc4Fuc1
99–122 1 missed cleavage
21–32 +Hex3HexNAc4Fuc1PC1
21–32 +Hex3HexNAc4Fuc1PC2
Fig. 2. Mass spectrometric analysis of Echinococcus granulosus antigen Ag5 tryptic (glyco)peptides. The revised sequence of the 38 kDa subunit of E. granulosus Ag5 is shown
with the detected peptides underlined and the N-glycosylation site in bold. The MALDI-TOF MS spectra show the peptides analysed with either (A) a-cyanocinnamic acid, (B)
sinapinic acid or (C) 6-aza-2-thiothymine as matrices. The inset in (A) shows the appearance of a peptide of m/z 1267.8 after PNGase A treatment of the tryptic peptides. (D
and E) MALDI-TOF MS/MS of them/z 2711 and 3041 molecular ions in (C) indicates the presence of fragments corresponding to unsubstituted terminal HexNAc (m/z 203.7) in
the former spectrum and phosphorylcholine-HexNAc (m/z 368.9) in the latter.
282 K. Paschinger et al. / International Journal for Parasitology 42 (2012) 279–285molecular ion was replaced by 1485.1, compatible with an [M+Na]+
form of Hex3HexNAc4dHex1 resulting from the loss of two phos-
phorylcholine moieties (Fig. 3B); the dHex residue was resistant
to this treatment. Thereby, the results of the glycopeptide analysis
when using ATT as a matrix could be explained by the presence of aglycan conferring an increase in mass of 1775 to the peptide
containing Asn25 (predicted mass 1265), thus resulting in a glyco-
peptide with m/z 3041.3.
The glycans released from the intact glycoprotein were also der-
ivatised with pyridylamine. In the subsequent mass spectrum, two
Fig. 3. Mass spectrometric analysis of Echinococcus granulosus antigen Ag5 N-glycans. MALDI-TOF MS spectra of N-glycans released from tryptic peptides of the 38 kDa
subunit of Ag5 with PNGase A before (A) and after treatment with hydroﬂuoric acid (B) and of N-glycans released with PNGase F from intact Ag5 after pyridylamination (C).
MALDI-TOF MS/MS spectra (D) of the major glycan in A and (E and F) of the two major pyridylaminated glycans in C, provide further compositional information. The predicted
structures of the major glycan and selected fragments are depicted according to the nomenclature of the Consortium for Functional Glycomics as well as in an abbreviated
code (H or circle, hexose; N or square, N-acetylhexosamine; F or triangle, fucose; PA, pyridylamine; PC, phosphorylcholine).
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(Fig. 3C); the increase in mass of 78 as compared to them/z value of
the underivatised 1793.6 glycan is due to the addition of pyridyl-
amine. Both species were subject to MS/MS (Fig. 3E and F), which
showed the presence of dominant fragments indicative of corefucose (HexNAc1dHex1PA; m/z 445.7) and terminal HexNAc (m/z
204.1) in the former and phosphorylcholine (HexNAc1PC1; m/z
368.9) in the latter. Our experience is that phosphorylcholine-con-
taining fragments dominate any MS/MS spectra (K. Paschinger,
unpublished observations); thereby core modiﬁcations are ‘hidden’
284 K. Paschinger et al. / International Journal for Parasitology 42 (2012) 279–285when analysing small amounts of such glycans. Compatible with
this, hydroﬂuoric acid treatment of the pyridylaminated glycans
resulted in a major product withm/z 1541 (data not shown) whose
MS/MS spectrum lacked the m/z 368 fragment, whereas the core
fucose fragment (m/z 446.2) was dominant (data similar to the
MS/MS in Fig. 3F). Considering the binding to Ag5 by AAL, the lack
of anti-horseradish peroxidase reactivity, the ability to cleave the
glycan with PNGase F, the absence of antennal fucose and the
insensitivity of the fucose residue to hydroﬂuoric acid (see above),
the dHex residue is concluded to be a core a1,6-fucose linked to
the reducing terminal GlcNAc residue.
The presence of pyridylaminated glycan species (m/z 1541.6
and 1706.8) lacking one or two phosphorylcholine moieties as
compared to the Hex3HexNAc4dHex1PC2 glycan was not expected
from the analyses of the underivatised glycans, but is rather com-
patible with the analyses of the glycopeptides which indicated a
degree of heterogeneity not apparent in the spectra of the free gly-
cans (see above). One may speculate that the presence of two phos-
phorylcholine moieties favourably alters the ionisation properties
of underivatised glycans, whereas the presence of either arginine
in the glycopeptide or pyridylamine label equalises ionisation of
all glycan species present.
3.4. Conclusion
Using MALDI-TOF MS of glycans and (glyco)peptides, as well as
conﬁrmatory western blotting evidence, we show that the Ag5
antigen 38 kDa subunit from E. granulosus is modiﬁed on a single
asparagine by a biantennary N-glycan decorated with up to two
phosphorylcholine and one core a1,6-fucose residues; the pres-
ence of core fucose on biantennary glycans has been previously
shown for both E. granulosus and E. multilocularis (Khoo et al.,
1997; Hülsmeier et al., 2010). In light of the structural evidence
presented here and our previous analysis of Ag5 antigenicity (Lore-
nzo et al., 2005b), we can conclude that the immunodominant N-
glycan moiety of Ag5 is a complex antibody binding site formed
by the sugar residues together with phosphorylcholine; indeed,
while removal of the whole N-glycan caused a dramatic loss of
immunoreactivity, inhibition experiments using monovalent phos-
phorylcholine only showed a modest decrease in reactivity.
Previous data have indicated Ag5-reactive sera cross-react with
other cestode and nematode species (Shepherd and McManus,
1987); also, phosphorylcholine-dependent cross-reactivity to-
wards cestode proteins of antibodies raised against nematode anti-
gens has been reported (Romaris et al., 2001). In other studies, the
presence of a phosphorylcholine-containing substance was indi-
cated immunologically for a ﬁsh tapeworm and correlates with
binding of cestode material to CRP (Fletcher et al., 1980; Taylor
and Hoole, 1997).
In this context, the present study is important in showing for
the ﬁrst time that phosphorylcholine is an actual covalent modiﬁ-
cation of the N-glycans of a cestode antigen; to our knowledge, this
is the ﬁrst evidence for the presence of this moiety on N-glycans in
a species other than nematodes such as Caenorhabditis elegans and
Ascaris suum (Paschinger et al., 2006; Pöltl et al., 2007). As phos-
phorylcholine is known to possess immunomodulatory properties
(Harnett and Harnett, 2001), its presence in a cestode suggests that
this glycan modiﬁcation may have been adopted during evolution,
as a means of manipulating host immune systems, by a wider
range of parasitic organisms than previously thought.
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